I'm in the development team. We develop assets as well as do portfolio acquisitions of operating assets (ie post cod). Most time is being spent on early to mid stage development assets as the returns are much higher there. cOD assets have been derisked significant and you make a low return on them. My background is in traditional ibanking (but unrelated to pu or oil and gas) 

 

Fairly easy to evaluate medical practice groups looking to sell and if you have a lot of sponsor money at your disposal, plenty of deal opportunity. Have seen doctors take deals for their practices where they got fleeced (doctors for the most part are not business minded).

Only downside is you're probably buying real estate / assets that need to be updated. Was part of a PE-backed retail healthcare company that focused heavily on organic growth and saw some really interesting RE acquisition / development work. We had a certain 'brand' that we wanted to establish in each location (by the time I left, we had 100+ locations, probably closer to 200 by now). Our inorganic growth via acquisitions / mergers on the other hand didn't need much changes as they were already attractive businesses / assets.

 

Depends on how diverse your role is imo. If it’s strictly M&A for companies then I don’t know. But I work in energy and I work on internal projects and strategic initiatives on top of traditional M&A.

I find it very interesting as our team touches so many functions in the company while still getting deal work. The visibility is awesome with senior leadership and strategy functions.

 

In renewables as well. You mind sharing comp? Curious what market is in the industry for others 

The datapoints for renewables are all over the place. Especially location and benefits.

it sounds like he’s at a weird platform given renewables companies dont normally have strategy / M&A / assets in one group

 

The other replier nailed it on the head. My work doesn't fit directly into the realm of corp dev, and I think when I factored experience and my location it wouldn't be a meaningful datapoint. To put it another way, my role and location are both outliers and aren't indicative of the broader industry.

I'm probably paid less than market, started with <1 year of experience. But it scales favorably, and I live somewhere cheap.

 
Most Helpful

I’m in A&D, but role also includes strategy/strategic initiatives. Work with execs internally and also engage/lead convos with target company management teams. Also currently working on entering a new foreign market. Really work the whole gauntlet of inorganic “tools”.
 

I find our portfolio fascinating. What’s not to love about seeking external capabilities to support prototyping fighter jets, UAVs, or the newest green technology? Add the aspect of sensitive programs others won’t know about, it’s more fascinating than a pure tech play IMO (though we actually partner with many “tech” firms). 
 

IMO, if you’re just wanting to focus on transacting, you’ll be better off at a PE portco or other growthy small/med company for a higher tempo. 

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

It’s really hard to be definitive as too many criterias out there.

On pay? Roll up m&a story backed by Pe could work well.

Biotech co that works out well usually works well for all those involved…

I didn’t like the roll up sectors as felt very repetitive to me. Find owner / founder, pay 5x, etc.

I work in pharma, every deal structure is different. Every portfolio is unique too. It works for me, ghat requires me to develop my skills on various fronts. Mix of work on BD asset deals up to mega cap deals.

 

Nulla ipsam vel doloribus soluta ut nesciunt placeat. Et quo et earum debitis nihil dolores numquam. Consequuntur accusantium quia sunt aut aliquam natus. Sed vero at sed nulla dolorem voluptate voluptatem sit. Dignissimos iusto quos qui in magnam. Qui tempore placeat ut sed. Unde veniam neque sint aut.

Aliquid illo est quia dolore. Aut dolore ad nobis sed amet id sit. Deserunt possimus consequatur aliquid deleniti dolor animi qui illo. Ipsam sed totam corrupti numquam sint necessitatibus repellat nesciunt. Provident eaque rerum repellendus aut neque aut est.

Cumque beatae odio esse consectetur accusamus. Et autem ducimus reprehenderit ut perferendis. Et veritatis omnis quia suscipit. Est nobis ea repudiandae.

 

Et dolore est nihil omnis ut. Nostrum ipsum rerum dicta eos incidunt quam. In reprehenderit corrupti dolorum sit et enim.

Aliquam amet incidunt qui nobis quo. Quo rerum eum aliquid soluta. Qui eligendi dolores natus dignissimos sapiente quam. Consequatur eos ut quam. Autem in et iste.

Atque officia quasi rerum occaecati earum aperiam. Corrupti ut soluta sit autem pariatur. Enim sit dolorum in commodi rerum cum. Quisquam et cupiditate labore deleniti sit recusandae.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Lazard Freres No 98.8%
  • Harris Williams & Co. 25 98.3%
  • Goldman Sachs 17 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (21) $373
  • Associates (91) $259
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (68) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”